Literature DB >> 3223324

Electrodermal activity in depressive patients in remission and in matched healthy subjects.

L H Thorell1, G d'Elia.   

Abstract

Electrodermal activity (EDA) was investigated in 28 patients when depressive and when in remission and in 28 matched and 59 unmatched healthy subjects. The follow-up period ranged from 3 to 37 months (median two years). All the EDA variables were significantly elevated at follow-up and did not differ significantly from the EDA of the matched healthy subjects. However, in patients with extremely low electrodermal responsivity (EDR) when depressed, including suicide attempters, EDA was significantly elevated, but did not reach the levels of the healthy subjects, except for one EDA variable. Further, patients with major depressive episode and a history of recurrent depression did not reach the EDR levels found in the healthy subjects. The results are interpreted as an indication that normalization of EDA does not parallel clinical recovery and may be extended for several months (perhaps years for the EDR), possibly indicating vulnerability to relapse. The data may also be interpreted that persons who are normally electrodermally hyporesponsive, may, when depressive, develop a state of extreme hyporesponsivity that seems to be linked to the ability to carry out a suicide attempt.

Entities:  

Mesh:

Year:  1988        PMID: 3223324     DOI: 10.1111/j.1600-0447.1988.tb06332.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

Review 1.  The association between electrodermal activity (EDA), depression and suicidal behaviour: A systematic review and narrative synthesis.

Authors:  Marco Sarchiapone; Carla Gramaglia; Miriam Iosue; Vladimir Carli; Laura Mandelli; Alessandro Serretti; Debora Marangon; Patrizia Zeppegno
Journal:  BMC Psychiatry       Date:  2018-01-25       Impact factor: 3.630

2.  EUDOR-A multi-centre research program: A naturalistic, European Multi-centre Clinical study of EDOR Test in adult patients with primary depression.

Authors:  Marco Sarchiapone; Miriam Iosue; Vladimir Carli; Mario Amore; Enrique Baca-Garcia; Anil Batra; Doina Cosman; Philippe Courtet; Guido Di Sciascio; Ricardo Gusmao; Tadeusz Parnowski; Peter Pestality; Pilar Saiz; Johannes Thome; Anders Tingström; Marcin Wojnar; Patrizia Zeppegno; Lars-Håkan Thorell
Journal:  BMC Psychiatry       Date:  2017-03-23       Impact factor: 3.630

3.  Clinical effectiveness of the electrodermal orienting reactivity test for evaluating relapse and recurrence risk in patients hospitalized for depression.

Authors:  Marta Litwińska-Bołtuć; Łukasz Święcicki; Armin Spreco; Toomas Timpka
Journal:  BMC Psychiatry       Date:  2021-02-10       Impact factor: 3.630

4.  A Naturalistic, European Multi-Center Clinical Study of Electrodermal Reactivity and Suicide Risk Among Patients With Depression.

Authors:  Vladimir Carli; Gergo Hadlaczky; Nuhamin Gebrewold Petros; Miriam Iosue; Patrizia Zeppegno; Carla Gramaglia; Mario Amore; Enrique Baca-Garcia; Anil Batra; Doina Cosman; Philippe Courtet; Guido Di Sciascio; Joakim Ekstrand; Hanga Galfalvy; Ricardo Gusmão; Catarina Jesus; Maria João Heitor; Miguel Constante; Pouya Movahed Rad; Pilar A Saiz; Marcin Wojnar; Marco Sarchiapone
Journal:  Front Psychiatry       Date:  2022-01-05       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.